RxDoctor Payments Data

Uma Swamy, MD

Radiation Oncology · Fresno, CANPI 1427377431

Payments from drug & device makers

$6,491in general payments, 2019–2025

Across 260 payments — averaging $24.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$900
  • Novartis$643
  • Merck$631
  • AstraZeneca$361
  • Takeda Pharmaceuticals U.S.A., Inc.$353
  • Eisai Inc.$295
  • plus $3K from 54 others

What the payments were for

  • Food & beverage$6,491100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(3 entities)29$900
Novartis29$643
Merck23$631
AstraZeneca(2 entities)17$361
Takeda Pharmaceuticals U.S.A., Inc.19$353
Eisai Inc.13$295
AbbVie9$224
Progenics Pharmaceuticals, Inc.5$199
Daiichi Sankyo Inc.9$191
Pfizer8$175
Seagen Inc.5$158
Amgen6$141
Pharmacosmos Therapeutics Inc.4$130
Pharmacyclics LLC, An Abbvie Company4$98
Taiho Oncology, Inc.4$97
Boehringer Ingelheim4$95
Myriad Genetic Laboratories, Inc.4$92
GT Medical Technologies, Inc1$85
Puma Biotechnology, Inc.3$80
Bayer3$78
Genentech USA, Inc.3$75
Tersera Therapeutics LLC3$69
Elekta, Inc.1$66
Rigel Pharmaceuticals, Inc.3$64
Springworks Therapeutics, Inc.2$57
Regeneron Healthcare Solutions, Inc.2$57
GSK2$57
Stemline Therapeutics Inc.2$50
Bristol Myers Squibb2$49
Incyte Corporation2$47
Siemens Medical Solutions USA, Inc.1$47
Acrotech Biopharma Inc.2$46
Sobi, Inc2$46
Foundation Medicine, Inc.3$45
Legend Biotech USA Inc.2$44
Novocure Inc.2$42
Gilead(2 entities)2$42
Astellas Pharma US Inc2$41
Mylan Institutional Inc.1$36
Karyopharm Therapeutics Inc.1$34
Corcept Therapeutics1$31
Geron Corporation1$30
Lilly USA, LLC1$29
Tempus AI, Inc1$28
Beone Medicines USA, Inc.1$27
Exelixis Inc.1$26
Sumitomo Pharma America, Inc.1$26
Pharmaessentia USA Corporation1$25
Jazz Pharmaceuticals Inc.1$22
Syndax Pharmaceuticals, Inc.1$22
Servier Pharmaceuticals LLC1$21
Morphosys, US Inc.1$21
Cardinal Health 414 LLC1$20
Telix Pharmaceuticals1$19
Global Blood Therapeutics, Inc.1$19
Agios Pharmaceuticals, Inc.1$17
Advanced Accelerator Applications1$15
Clovis Oncology, Inc.1$14
Alnylam Pharmaceuticals Inc.1$14
Medtronic1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,491 in reported general payments places this provider in the 80th percentile of 627 radiation oncology providers in California.

See all radiation oncology providers in California

Medicare billing

Part B allowed, 2024
$2,544,126
Medicare patients
213
Services billed
11,636

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dexamethasone18$264

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Fresno

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →